Linked Open drug data for pharmaceutical research and development

163Citations
Citations of this article
240Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is an abundance of information about drugs available on the Web. Data sources range from medicina chemistry results, over the impact of drugs on gene expression, to the outcomes of drugs in clinical trials. These data are typically not connected together, which reduces the ease with which insights can be gained. Linking Open Drug Data (LODD) is a task force within the World Wide Web Consortium's (W3C) Health Care and Life Sciences Interest Group (HCLS IG). LODD has surveyed publicly available data about drugs, created Linked Data representations of the data sets, and identified interesting scientific and business questions that can be answered once the data sets are connected. The task force provides recommendations for the best practices of exposing data in a Linked Data representation. In this paper, we present past and ongoing work of LODD and discuss the growing importance of Linked Data as a foundation for pharmaceutical R&D data sharing. © 2011 Samwald et al; licensee Chemistry Central Ltd.

Cite

CITATION STYLE

APA

Samwald, M., Jentzsch, A., Bouton, C., Kallesøe, C. S., Willighagen, E., Hajagos, J., … Stephens, S. (2011). Linked Open drug data for pharmaceutical research and development. Journal of Cheminformatics, 3(5). https://doi.org/10.1186/1758-2946-3-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free